130 related articles for article (PubMed ID: 34567156)
1. Efficacy and Safety of Melatonin as an Adjunctive Therapy on Clinical, Biochemical, and Quality of Life in Patients with Ulcerative Colitis.
Shahrokh S; Qobadighadikolaei R; Abbasinazari M; Haghazali M; Asadzadeh Aghdaei H; Abdi S; Balaii H; Khanzadeh-Moghaddam N; Zali MR
Iran J Pharm Res; 2021; 20(2):197-205. PubMed ID: 34567156
[TBL] [Abstract][Full Text] [Related]
2. Short-term effect of gluten-free diet on disease severity, quality of life, and inflammatory markers among patients with mild to moderate ulcerative colitis: A triple-blind randomized placebo-controlled trial.
Alborzi Avanaki F; Ebrahimi Daryani N; Aletaha N; Hesabgar N; Rezaee-Zavareh MS; Hadi R
Arab J Gastroenterol; 2024 May; ():. PubMed ID: 38714473
[TBL] [Abstract][Full Text] [Related]
3. Fecal calprotectin and its correlation with inflammatory markers and endoscopy in patients from India with inflammatory bowel disease.
Samant H; Desai D; Abraham P; Joshi A; Gupta T; Dherai A; Ashavaid T
Indian J Gastroenterol; 2015 Nov; 34(6):431-5. PubMed ID: 26589229
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of noninvasive evaluations in monitoring inflammatory bowel disease activity: A prospective study in China.
Chen JM; Liu T; Gao S; Tong XD; Deng FH; Nie B
World J Gastroenterol; 2017 Dec; 23(46):8235-8247. PubMed ID: 29290660
[TBL] [Abstract][Full Text] [Related]
5. The correlation between fecal calprotectin, simple clinical colitis activity index and biochemical markers in ulcerative colitis during high-dose steroid treatment.
Theede K; Kiszka-Kanowitz M; Nielsen AM; Nordgaard-Lassen I
Scand J Gastroenterol; 2014 Apr; 49(4):418-23. PubMed ID: 24495103
[TBL] [Abstract][Full Text] [Related]
6. Eicosapentaenoic Acid Reduces Fecal Levels of Calprotectin and Prevents Relapse in Patients With Ulcerative Colitis.
Scaioli E; Sartini A; Bellanova M; Campieri M; Festi D; Bazzoli F; Belluzzi A
Clin Gastroenterol Hepatol; 2018 Aug; 16(8):1268-1275.e2. PubMed ID: 29391271
[TBL] [Abstract][Full Text] [Related]
7. Clinical value of fecal calprotectin in determining disease activity of ulcerative colitis.
Xiang JY; Ouyang Q; Li GD; Xiao NP
World J Gastroenterol; 2008 Jan; 14(1):53-7. PubMed ID: 18176961
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of a standardized extract from Achillea wilhelmsii C. Koch in patients with ulcerative colitis: A randomized double blind placebo-controlled clinical trial.
Amiri M; Navabi J; Shokoohinia Y; Heydarpour F; Bahrami G; Behbood L; Derakhshandeh P; Momtaz S; Farzaei MH
Complement Ther Med; 2019 Aug; 45():262-268. PubMed ID: 31331572
[TBL] [Abstract][Full Text] [Related]
9. The effect of curcumin supplementation on clinical outcomes and inflammatory markers in patients with ulcerative colitis.
Sadeghi N; Mansoori A; Shayesteh A; Hashemi SJ
Phytother Res; 2020 May; 34(5):1123-1133. PubMed ID: 31802559
[TBL] [Abstract][Full Text] [Related]
10. eHealth: individualization of mesalazine treatment through a self-managed web-based solution in mild-to-moderate ulcerative colitis.
Pedersen N; Thielsen P; Martinsen L; Bennedsen M; Haaber A; Langholz E; Végh Z; Duricova D; Jess T; Bell S; Burisch J; Munkholm P
Inflamm Bowel Dis; 2014 Dec; 20(12):2276-85. PubMed ID: 25248002
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of melatonin effectiveness in the adjuvant treatment of ulcerative colitis.
Chojnacki C; Wisniewska-Jarosinska M; Walecka-Kapica E; Klupinska G; Jaworek J; Chojnacki J
J Physiol Pharmacol; 2011 Jun; 62(3):327-34. PubMed ID: 21893693
[TBL] [Abstract][Full Text] [Related]
12. The patient simple clinical colitis activity index (P-SCCAI) can detect ulcerative colitis (UC) disease activity in remission: a comparison of the P-SCCAI with clinician-based SCCAI and biological markers.
Bennebroek Evertsz' F; Nieuwkerk PT; Stokkers PC; Ponsioen CY; Bockting CL; Sanderman R; Sprangers MA
J Crohns Colitis; 2013 Dec; 7(11):890-900. PubMed ID: 23269224
[TBL] [Abstract][Full Text] [Related]
13. Effects of soy milk consumption on gut microbiota, inflammatory markers, and disease severity in patients with ulcerative colitis: a study protocol for a randomized clinical trial.
Sadeghi O; Milajerdi A; Siadat SD; Keshavarz SA; Sima AR; Vahedi H; Adibi P; Esmaillzadeh A
Trials; 2020 Jun; 21(1):565. PubMed ID: 32576228
[TBL] [Abstract][Full Text] [Related]
14. Effects of coenzyme Q10 on health-related quality of life, clinical disease activity and blood pressure in patients with mild to moderate ulcerative colitis: a randomized clinical trial.
Farsi F; Ebrahimi-Daryani N; Barati M; Janani L; Karimi MY; Akbari A; Irandoost P; Mesri Alamdari N; Agah S; Vafa M
Med J Islam Repub Iran; 2021; 35():3. PubMed ID: 33996654
[No Abstract] [Full Text] [Related]
15. The sensitivity of fecal calprotectin in predicting deep remission in ulcerative colitis.
Carlsen K; Riis LB; Elsberg H; Maagaard L; Thorkilgaard T; Sørbye SW; Jakobsen C; Wewer V; Florholmen J; Goll R; Munkholm P
Scand J Gastroenterol; 2018; 53(7):825-830. PubMed ID: 29968483
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Melatonin Secretion and Metabolism Exponents in Patients with Ulcerative and Lymphocytic Colitis.
Chojnacki C; Błasiak J; Fichna J; Chojnacki J; Popławski T
Molecules; 2018 Jan; 23(2):. PubMed ID: 29382152
[TBL] [Abstract][Full Text] [Related]
17. Fecal calprotectin predicts complete mucosal healing and better correlates with the ulcerative colitis endoscopic index of severity than with the Mayo endoscopic subscore in patients with ulcerative colitis.
Lee SH; Kim MJ; Chang K; Song EM; Hwang SW; Park SH; Yang DH; Kim KJ; Byeon JS; Myung SJ; Yang SK; Ye BD
BMC Gastroenterol; 2017 Oct; 17(1):110. PubMed ID: 29061121
[TBL] [Abstract][Full Text] [Related]
18. Chinese herbal extract granules combined with 5-aminosalicylic acid for patients with moderately active ulcerative colitis: study protocol for a multicenter randomized double-blind placebo-controlled trial.
Shen Z; Zheng K; Zou J; Gu P; Xing J; Zhang L; Zhu L; Shen H
Trials; 2021 Jan; 22(1):55. PubMed ID: 33441157
[TBL] [Abstract][Full Text] [Related]
19. Multidonor FMT capsules improve symptoms and decrease fecal calprotectin in ulcerative colitis patients while treated - an open-label pilot study.
Cold F; Browne PD; Günther S; Halkjaer SI; Petersen AM; Al-Gibouri Z; Hansen LH; Christensen AH
Scand J Gastroenterol; 2019 Mar; 54(3):289-296. PubMed ID: 30946615
[No Abstract] [Full Text] [Related]
20. Correlation of Biomarkers with Endoscopic Score: Ulcerative Colitis Endoscopic Index of Severity (UCEIS) in Patients with Ulcerative Colitis in Remission.
Pop CS; Filip PV; Diaconu SL; Matei C; Furtunescu F
Medicina (Kaunas); 2020 Dec; 57(1):. PubMed ID: 33396524
[No Abstract] [Full Text] [Related]
[Next] [New Search]
